Literature DB >> 21905680

Deconstruction of the α4β2 nicotinic acetylcholine receptor positive allosteric modulator desformylflustrabromine.

Nadezhda German1, Jin-Sung Kim, Atul Jain, Malgorzata Dukat, Anshul Pandya, Yilong Ma, Maegan Weltzin, Marvin K Schulte, Richard A Glennon.   

Abstract

Desformylflustrabromine (dFBr; 1), perhaps the first selective positive allosteric modulator of α4β2 neuronal nicotinic acetylcholine (nACh) receptors, was deconstructed to determine which structural features contribute to its actions on receptors expressed in Xenopus ooycytes using two-electrode voltage clamp techniques. Although the intact structure of 1 was found to be optimal, several deconstructed analogs retained activity. Neither the 6-bromo substituent nor the entire 2-position chain is required for activity. In particular, reduction of the olefinic side chain of 1, as seen with 6, not only resulted in retention of activity/potency but in enhanced selectivity for α4β2 versus α7 nACh receptors. Pharmacophoric features for the allosteric modulation of α4β2 nACh receptors by 1 were identified.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21905680      PMCID: PMC3200116          DOI: 10.1021/jm200834x

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

Review 1.  2. Medicinal chemistry of alpha4beta2 nicotinic cholinergic receptor ligands.

Authors:  Richard A Glennon
Journal:  Prog Med Chem       Date:  2004

Review 2.  Positive and negative modulation of nicotinic receptors.

Authors:  Hugo R Arias
Journal:  Adv Protein Chem Struct Biol       Date:  2010       Impact factor: 3.507

Review 3.  Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.

Authors:  John A Dani; Daniel Bertrand
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

Review 4.  Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors.

Authors:  Hugo R Arias; Pankaj Bhumireddy; Cecilia Bouzat
Journal:  Int J Biochem Cell Biol       Date:  2006-02-20       Impact factor: 5.085

5.  Allosteric modulation of nicotinic acetylcholine receptors.

Authors:  Daniel Bertrand; Murali Gopalakrishnan
Journal:  Biochem Pharmacol       Date:  2007-07-14       Impact factor: 5.858

6.  Potentiation of human alpha4beta2 neuronal nicotinic receptors by a Flustra foliacea metabolite.

Authors:  Francisco Sala; José Mulet; Krishna P Reddy; José Antonio Bernal; Philip Wikman; Luis Miguel Valor; Lars Peters; Gabriele M König; Manuel Criado; Salvador Sala
Journal:  Neurosci Lett       Date:  2005-01-10       Impact factor: 3.046

7.  Prenylated indole alkaloids from Flustra foliacea with subtype specific binding on NAChRs.

Authors:  Lars Peters; Anthony D Wright; Stefan Kehraus; Daniela Gündisch; M C Tilotta; Gabriele M König
Journal:  Planta Med       Date:  2004-10       Impact factor: 3.352

8.  Pharmacological characterization of the allosteric modulator desformylflustrabromine and its interaction with alpha4beta2 neuronal nicotinic acetylcholine receptor orthosteric ligands.

Authors:  Maegan M Weltzin; Marvin K Schulte
Journal:  J Pharmacol Exp Ther       Date:  2010-06-01       Impact factor: 4.030

9.  A vertical flow chamber for Xenopus oocyte electrophysiology and automated drug screening.

Authors:  P R Joshi; A Suryanarayanan; M K Schulte
Journal:  J Neurosci Methods       Date:  2004-01-15       Impact factor: 2.390

10.  Synthesis of desformylflustrabromine and its evaluation as an alpha4beta2 and alpha7 nACh receptor modulator.

Authors:  Jin-Sung Kim; Anshul Padnya; Maegan Weltzin; Brian W Edmonds; Marvin K Schulte; Richard A Glennon
Journal:  Bioorg Med Chem Lett       Date:  2007-06-14       Impact factor: 2.823

  10 in total
  7 in total

1.  Desformylflustrabromine (dFBr) and [3H]dFBr-Labeled Binding Sites in a Nicotinic Acetylcholine Receptor.

Authors:  Ayman K Hamouda; Ze-Jun Wang; Deirdre S Stewart; Atul D Jain; Richard A Glennon; Jonathan B Cohen
Journal:  Mol Pharmacol       Date:  2015-04-13       Impact factor: 4.436

Review 2.  Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors.

Authors:  Jingyi Wang; Jon Lindstrom
Journal:  Br J Pharmacol       Date:  2017-03-20       Impact factor: 8.739

3.  Levamisole: A Positive Allosteric Modulator for the α3β4 Nicotinic Acetylcholine Receptors Prevents Weight Gain in the CD-1 Mice on a High Fat Diet.

Authors:  Jeanne A Lewis; Jerrel L Yakel; Anshul A Pandya
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

4.  Activation of the α7 nicotinic ACh receptor induces anxiogenic effects in rats which is blocked by a 5-HT₁a receptor antagonist.

Authors:  Anshul A Pandya; Jerrel L Yakel
Journal:  Neuropharmacology       Date:  2013-01-12       Impact factor: 5.250

Review 5.  Recent progress in neuroactive marine natural products.

Authors:  Ryuichi Sakai; Geoffrey T Swanson
Journal:  Nat Prod Rep       Date:  2014-01-17       Impact factor: 13.423

Review 6.  Effects of neuronal nicotinic acetylcholine receptor allosteric modulators in animal behavior studies.

Authors:  Anshul A Pandya; Jerrel L Yakel
Journal:  Biochem Pharmacol       Date:  2013-05-31       Impact factor: 5.858

7.  Osteocompatibility of biofilm inhibitors.

Authors:  Monica Rawson; Warren Haggard; Jessica A Jennings
Journal:  Open Orthop J       Date:  2014-11-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.